Antiaging Quantum Living Cash & Equivalents Growth & History (AAQL)
Antiaging Quantum Living's cash and equivalents was $503,486 for fiscal 2026.
View full Antiaging Quantum Living company overviewAntiaging Quantum Living annual cash and equivalents history
| Fiscal year | Period ended | Cash and equivalents | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $503,486 | $132,937 | +35.88% |
| 2025 | 2025-03-31 | $370,549 | $203,997 | +122.48% |
| 2024 | 2024-03-31 | $166,552 | $166,198 | +46948.59% |
| 2023 | 2023-03-31 | $354 | −$13,915 | −97.52% |
| 2022 | 2022-03-31 | $14,269 | −$3,227 | −18.44% |
| 2021 | 2021-03-31 | $17,496 | −$43,975 | −71.54% |
| 2020 | 2020-03-31 | $61,471 | $57,330 | +1384.45% |
| 2019 | 2019-03-31 | $4,141 | $2,630 | +174.06% |
| 2018 | 2018-03-31 | $1,511 | −$124 | −7.58% |
| 2017 | 2017-03-31 | $1,635 | — | — |
Antiaging Quantum Living quarterly cash and equivalents
| Fiscal quarter | Period ended | Cash and equivalents | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $608,100 | $202,375 | +49.88% |
| Q4 2026 | 2026-03-31 | $503,486 | $132,937 | +35.88% |
| Q3 2026 | 2025-12-31 | $936,910 | $734,423 | +362.70% |
| Q2 2026 | 2025-09-30 | $455,446 | $418,043 | +1117.67% |
| Q1 2026 | 2025-06-30 | $405,725 | $283,074 | +230.80% |
| Q4 2025 | 2025-03-31 | $370,549 | $203,997 | +122.48% |
| Q3 2025 | 2024-12-31 | $202,487 | $76,839 | +61.15% |
| Q2 2025 | 2024-09-30 | $37,403 | −$17,631 | −32.04% |
| Q1 2025 | 2024-06-30 | $122,651 | $88,327 | +257.33% |
| Q4 2024 | 2024-03-31 | $166,552 | $166,198 | +46948.59% |
| Q3 2024 | 2023-12-31 | $125,648 | $124,747 | +13845.39% |
| Q2 2024 | 2023-09-30 | $55,034 | $53,733 | +4130.13% |
| Q1 2024 | 2023-06-30 | $34,324 | $32,885 | +2285.27% |
| Q4 2023 | 2023-03-31 | $354 | −$13,915 | −97.52% |
| Q3 2023 | 2022-12-31 | $901 | −$14,593 | −94.18% |
| Q2 2023 | 2022-09-30 | $1,301 | −$46,871 | −97.30% |
| Q1 2023 | 2022-06-30 | $1,439 | $154 | +11.98% |
| Q4 2022 | 2022-03-31 | $14,269 | −$3,227 | −18.44% |
| Q3 2022 | 2021-12-31 | $15,494 | −$11,502 | −42.61% |
| Q2 2022 | 2021-09-30 | $48,172 | $19,820 | +69.91% |
| Q1 2022 | 2021-06-30 | $1,285 | −$49,616 | −97.48% |
| Q4 2021 | 2021-03-31 | $17,496 | −$43,975 | −71.54% |
| Q3 2021 | 2020-12-31 | $26,996 | −$54,689 | −66.95% |
| Q2 2021 | 2020-09-30 | $28,352 | −$112,960 | −79.94% |
| Q1 2021 | 2020-06-30 | $50,901 | $42,195 | +484.67% |
| Q4 2020 | 2020-03-31 | $61,471 | $57,330 | +1384.45% |
| Q3 2020 | 2019-12-31 | $81,685 | $78,546 | +2502.26% |
| Q2 2020 | 2019-09-30 | $141,312 | $129,209 | +1067.58% |
| Q1 2020 | 2019-06-30 | $8,706 | −$3,143 | −26.53% |
| Q4 2019 | 2019-03-31 | $4,141 | $2,630 | +174.06% |
| Q3 2019 | 2018-12-31 | $3,139 | $940 | +42.75% |
| Q2 2019 | 2018-09-30 | $12,103 | $10,247 | +552.10% |
| Q1 2019 | 2018-06-30 | $11,849 | $9,993 | +538.42% |
| Q4 2018 | 2018-03-31 | $1,511 | −$124 | −7.58% |
| Q3 2018 | 2017-12-31 | $2,199 | — | — |
| Q2 2018 | 2017-09-30 | $1,856 | — | — |
| Q1 2018 | 2017-06-30 | $1,856 | — | — |
| Q4 2017 | 2017-03-31 | $1,635 | — | — |
Antiaging Quantum Living cash and equivalents trends
Over the last five fiscal years, Antiaging Quantum Living's cash and equivalents increased from $17,496 to $503,486, a change of $485,990. The latest reported quarter, Q1 2027, shows $608,100.
What cash and equivalents mean
Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.
Reported cash and equivalents
TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Antiaging Quantum Living source filings ↗